|
|
|
 |
|
|
 |
 |
Dynavax Technologies Corporation
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Dynavax Technologies Corporation. The Group's principal activity is to develop and discover novel products to prevent and treat infectious diseases. It's lead product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine.
|
|
| |
Wright Quality Rating:
LCNN Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/5/2010):
1.48
(Figures in
U.S. Dollars) |
|
1 Week |
1.4% |
|
13 Weeks |
-3.9% |
|
|
|
|
|
|
|
|
|
4 Weeks |
15.6% |
|
52 Weeks |
138.7% |
|
|
|
| |
| |
Dynavax Technologies Corporation
Key Data: |
|
|
|
| |
Ticker: |
DVAX |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Miscellaneous |
| |
|
| |
|
|
Sub Industry: |
Medical Services |
| |
|
| |
2008
Sales |
37,094,000
(Year Ending Jan 2009). |
Employees: |
155 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
61,093,320 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
41,279,270 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
11,599,582 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Dynavax Technologies Corporation, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Dynavax Technologies Corporation company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Dynavax Technologies Corporation Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Dynavax Technologies Corporation
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Dynavax Technologies Corporation Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|